Charité - Universitätsmedizin Berlin

Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts. (2023) Canney M, Induruwage D, Tang M, Alencar de Pinho N, Er L, Zhao Y, Djurdjev O, et al. Journal article Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. (2023) Agarwal R, Tu W, Farjat AE, Farag YM, Toto R, Kaul S, Lawatscheck R, et al. Journal article Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. (2023) Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar De Pinho N, et al. Journal article Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. (2023) Koehm M, Foldenauer AC, Rossmanith T, Kellner H, Kiltz U, Burmester GR, Kofler DM, et al. Journal article [Treatment of Persistent Parenchymal Lung Injuries in Thoracic Trauma: Lung Laceration, Pleural Fistula and Pneumothorax]. (2023) Neudecker J, Schulz-Drost S, Walles T Journal article [VATS in Thorax Trauma]. (2023) Schreyer C, Eckermann C, Neudecker J, Becker L, Schulz-Drost S Journal article In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant (2022) Heinen N, Marheinecke CS, Bessen C, Blazquez-Navarro A, Roch T, Stervbo U, Anft M, et al. Journal article Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry (2022) Hanschmann T, Francuzik W, Doelle-Bierke S, Hofmeier KS, Grabenhenrich L, Rueff F, Renaudin JM, et al. Journal article "Nothing works without the doctor:" Physicians' perception of clinical decision-making and artificial intelligence (2022) Samhammer D, Roller R, Hummel P, Osmanodja B, Burchardt A, Mayrdorfer M, Duettmann W, Dabrock P Journal article Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland (2022) Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akcetin L, et al. Journal article